Errors were subsequently identified in the article, and the following corrections should be noted:
In Section 3.2.2.1, paragraph 1, lines 185-192: The following three sentences, which previously read:
''Compared with mtDNA point mutations, single largescale mtDNA deletions usually represent de novo mutational events occurring either in an oocyte or during embryogenesis [5] . Therefore, only the proband is usually affected in the family, but there is nevertheless a low risk of transmission by the mother of an affected child. The recurrence risk for a single, large-scale mtDNA deletion has been estimated at'' should read:
''Compared with mtDNA point mutations, single largescale mtDNA deletions are usually sporadic. Therefore, only the proband is usually affected in the family. There is nevertheless a low risk of transmission by the mother of an affected child with the estimated recurrence risk for a single large-scale mtDNA deletion being 1 in 117 (*4%) ' In a particular case with maternally inherited diabetes and deafness (MIDD) and complex-I deficiency in fibroblasts, mtDNA sequencing revealed a heteroplasmic insertion of one or two cytosine residues in the coding region of the MT-ND6 gene (m.14535_14536insC or CC), leading to a premature stop codon [25] . A 9-bp triplication in the MT-CYTB gene was detected in an African patient with isolated mitochondrial myopathy [24] . In a patient with dilated cardiomyopathy, the causative mutation was a 15 bp duplication in the tRNA Pro gene [26] . [25] . While the phenotype can be classical Kearns-Sayre syndrome, endocrinopathies are common and families may manifest maternally inherited diabetes and deafness (MIDD). In one family with MIDD associated with a complex 1 deficiency in fibroblasts, mtDNA sequencing revealed a heteroplasmic insertion of one or two cytosine residues in the coding region of the MT-ND6 gene (m.14535_14536insC or CC), leading to a premature stop codon [26] . 
